Explore the latest developments concerning Pfizer Wins Obesity.
Pfizer Wins Obesity Drug Prize, With Trump Administration Assist
(Bloomberg) — Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he learned he’d finally claimed his prize.
Bourla found out at around 9 p.m. that evening, according to people familiar with the matter, that the board of Metsera Inc., a three-year-old biotech startup developing a new generation of weight-loss drugs, had voted unanimously to accept Pfizer’s takeover offer of as much as $10 billion.
A Housing Complex Designed to Tackle Loneliness Wins Britain’s Best Building
New Monopolar RF Face Skin Rejuvenation Ultra 2 IN 1 360 Body Contouring Cellulite Reduction Tightening Machine
The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.
For more detailed information, explore updates concerning Pfizer Wins Obesity.